A team led by researchers at Chalmers University of Technology, Sweden, has succeeded in identifying biomarkers for Parkinson's disease in its earliest stages, before extensive brain damage has ...

TRPML1 is a promising target1 for Parkinson’s disease treatments and identifying translational biomarkers will help confirm target engagement ...

Personalized medicine promises to significantly improve patient outcomes, but achieving this requires a deep understanding of human health and disease mechanisms at the molecular level. The advent of ...

Join us for a science symposium where cutting-edge biology meets transformative technology. Dive deep into molecular research using the latest multiomics advances, from the granularity of single-cell ...

Biomarkers are critical tools for detecting and monitoring disease, understanding pathogenic mechanisms, and tracking therapeutic responses. From proteomic profiling to AI-based algorithms, scientists ...

In recent years, the field of oncology has increasingly acknowledged cancer as a metabolic disorder with significant nutritional determinants. The advent of ...

Researchers have traditionally employed histopathology techniques, which involve the microscopic examination of tissue, to gain insight into disease processes. This approach often leads to subjective ...

Collaboration to leverage Lunit SCOPE IO ® and SCOPE universal IHC® (uIHC) digital pathology products in two Daiichi Sankyo oncology research and development programs SEOUL, South Korea, Dec. 15, 2025 ...

NEW YORK CITY, NEW YORK / ACCESS Newswire / September 25, 2025 / Lunai Bioworks Inc. (NASDAQ:RENB), an AI-powered drug discovery company and parent of wholly owned subsidiary BioSymetrics, today ...

The global biomarkers market size is reached at USD 118.32 billion in 2026 and is projected to hit USD 366.64 billion by 2035, growing at impressive CAGR of 13.39% from 2026 to 2035.Ottawa, Jan. 28, ...